Johnson MA - Search Results

1

In vivo HIV-1 replicative capacity in early and advanced infection.

Phillips AN, McLean AR, Loveday C, Tyrer M, Bofill M, Devereux H, Madge S, Dykoff A, Drinkwater A, Burke A, Huckett L, Janossy G, Johnson MA. Phillips AN, et al. Among authors: johnson ma. AIDS. 1999 Jan 14;13(1):67-73. doi: 10.1097/00002030-199901140-00009. AIDS. 1999. PMID: 10207546

2

Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells.

Borthwick NJ, Bofill M, Gombert WM, Akbar AN, Medina E, Sagawa K, Lipman MC, Johnson MA, Janossy G. Borthwick NJ, et al. Among authors: johnson ma. AIDS. 1994 Apr;8(4):431-41. doi: 10.1097/00002030-199404000-00004. AIDS. 1994. PMID: 8011246

3

Lymphocyte activation in HIV-1 infection. I. Predominant proliferative defects among CD45R0+ cells of the CD4 and CD8 lineages.

Janossy G, Borthwick N, Lomnitzer R, Medina E, Squire SB, Phillips AN, Lipman M, Johnson MA, Lee C, Bofill M. Janossy G, et al. Among authors: johnson ma. AIDS. 1993 May;7(5):613-24. doi: 10.1097/00002030-199305000-00002. AIDS. 1993. PMID: 8318170

4

Will we ever know when to treat HIV infection?

Phillips AN, Smith GD, Johnson MA. Phillips AN, et al. Among authors: johnson ma. BMJ. 1996 Sep 7;313(7057):608-10. doi: 10.1136/bmj.313.7057.608. BMJ. 1996. PMID: 8806255 Free PMC article. Review.

5

Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients.

Bofill M, Mocroft A, Lipman M, Medina E, Borthwick NJ, Sabin CA, Timms A, Winter M, Baptista L, Johnson MA, Lee CA, Phillips AN, Janossy G. Bofill M, et al. Among authors: johnson ma. AIDS. 1996 Jul;10(8):827-34. doi: 10.1097/00002030-199607000-00005. AIDS. 1996. PMID: 8828739

6

HIV-1 dynamics after transient antiretroviral therapy: implications for pathogenesis and clinical management.

Phillips AN, McLean A, Johnson MA, Tyrer M, Emery V, Griffiths P, Bofill M, Janossy G, Loveday C. Phillips AN, et al. Among authors: johnson ma. J Med Virol. 1997 Nov;53(3):261-5. J Med Virol. 1997. PMID: 9365893

7

HIV suppression and risk of drug resistance mutations.

Phillips AN, Loveday C, Johnson MA. Phillips AN, et al. Among authors: johnson ma. AIDS. 1998 Oct 1;12(14):1930. AIDS. 1998. PMID: 9792396 No abstract available.

8

The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997. Royal Free Centre for HIV Medicine.

Mocroft A, Barry S, Sabin CA, Lepri AC, Kinloch S, Drinkwater A, Lipman M, Youle M, Johnson MA, Phillips AN. Mocroft A, et al. Among authors: johnson ma. AIDS. 1999 Jul 9;13(10):1255-61. doi: 10.1097/00002030-199907090-00016. AIDS. 1999. PMID: 10416531

9

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy.

Devereux HL, Youle M, Johnson MA, Loveday C. Devereux HL, et al. Among authors: johnson ma. AIDS. 1999 Dec 24;13(18):F123-7. AIDS. 1999. PMID: 10630517

10

Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. Royal Free Centre for HIV Medicine.

Mocroft A, Devereux H, Kinloch-de-Loes S, Wilson D, Madge S, Youle M, Tyrer M, Loveday C, Phillips AN, Johnson MA. Mocroft A, et al. Among authors: johnson ma. AIDS. 2000 Jul 28;14(11):1545-52. doi: 10.1097/00002030-200007280-00010. AIDS. 2000. PMID: 10983641 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,706 results

Search Page

Filters